| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/17/2009 | WO2009114865A2 Methods to determine susceptibility to treatment with leukotriene modifiers |
| 09/17/2009 | WO2009114862A1 Dna repair proteins associated with triple negative breast cancers and methods of use thereof |
| 09/17/2009 | WO2009114836A1 Gene expression markers for prediction of patient response to chemotherapy |
| 09/17/2009 | WO2009114776A2 Integrin targeting agents and methods of using same |
| 09/17/2009 | WO2009114748A1 Immuno-based botulinum toxin serotype a activity assays |
| 09/17/2009 | WO2009114709A2 Detection of polymeric analytes |
| 09/17/2009 | WO2009114699A2 High molecular weight ngal as a biomarker for chronic kidney disease |
| 09/17/2009 | WO2009114679A2 Treatment of pompe disease with specific pharmacological chaperones and monitoring treatment using surrogate markers |
| 09/17/2009 | WO2009114641A1 Antibodies with enhanced adcc function |
| 09/17/2009 | WO2009114579A2 Reducing/oxidizing activity of maternal urine as indicator of fetal gender related characteristics |
| 09/17/2009 | WO2009114522A2 Compositions, kits and methods for determining etiology of trali and detecting patients at risk for this transfusion reaction |
| 09/17/2009 | WO2009114515A1 Fluorescent dye tracer method for animal feed supplement products |
| 09/17/2009 | WO2009114496A1 Density-based cell detection system |
| 09/17/2009 | WO2009114333A2 Particle agglutination in a tip |
| 09/17/2009 | WO2009114292A1 Copd biomarker signatures |
| 09/17/2009 | WO2009114188A1 Newcastle disease virus monoclonal antibodies |
| 09/17/2009 | WO2009114182A1 Labeled reactants and their uses |
| 09/17/2009 | WO2009114083A2 Determinants of antiviral response |
| 09/17/2009 | WO2009114011A1 Histone demethylation proteins and methods of use thereof |
| 09/17/2009 | WO2009113880A1 Biomarkers |
| 09/17/2009 | WO2009113879A1 Biomarkers |
| 09/17/2009 | WO2009113859A1 Cervical screening algorithms |
| 09/17/2009 | WO2009113857A1 Method, system and computer program for contactless measuring a moisture percentage |
| 09/17/2009 | WO2009113704A2 Fluorine-containing compound and method for detecting biomolecule using the same |
| 09/17/2009 | WO2009113495A1 Liver cancer detection method using gene capable of being expressed in liver cancer-specific manner, and therapeutic and prophylactic agent for liver cancer |
| 09/17/2009 | WO2009113480A1 Therapeutic agent for cerebral infarction |
| 09/17/2009 | WO2009113446A1 Skin whitening method and screening method for factors for skin wrinkle formation suppression and/or removal |
| 09/17/2009 | WO2009113375A1 Silicon oxide film containing silicon nanoparticle phosphor, silicon nanoparticle phosphor, and single molecule observation method |
| 09/17/2009 | WO2009113374A1 Marking method |
| 09/17/2009 | WO2009113303A1 Method for detection of methylcytosine using photoresponsive probe |
| 09/17/2009 | WO2009113295A1 C2orf18 as target gene for cancer therapy and diagnosis |
| 09/17/2009 | WO2009113158A1 Method for immobilizing biologically active substance |
| 09/17/2009 | WO2009113044A2 Method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) and related technologies |
| 09/17/2009 | WO2009113010A1 A sensor device and a method of detecting compounds, particles or complexes |
| 09/17/2009 | WO2009112880A1 A method and system for monitoring horizontal gene transfer in living and fixed cells, and uses thereof |
| 09/17/2009 | WO2009112831A1 Immunotherapeutic methods and molecules |
| 09/17/2009 | WO2009112791A1 Fluorogenic peptides and their method of production |
| 09/17/2009 | WO2009112747A1 Device for measuring the concentration of sulphide ions in a fluid from a well, and associated equipment |
| 09/17/2009 | WO2009112713A1 Radar operation apparatus for detecting and locating discontinuities or foreign bodies in materials |
| 09/17/2009 | WO2009112702A2 Method for in vitro detection and/or quantification and/or identification of bacteria in a biological material |
| 09/17/2009 | WO2009112701A2 Method for in vitro detection and/or quantification and/or identification of infectious compounds in a biological material |
| 09/17/2009 | WO2009112692A2 Reaction cuvette supply to an automatic analysis machine |
| 09/17/2009 | WO2009112670A2 Use of a protein or nitrated peptide sequence for implementing a diagnosis method |
| 09/17/2009 | WO2009112627A1 Method and device for measurement of properties of wood |
| 09/17/2009 | WO2009112592A1 In vitro method to determine whether a drug candidate active against a target protein is active against a variant of said protein |
| 09/17/2009 | WO2009112542A1 Screening for compounds having immunosuppressant activity by testing impact on leukocyte-specific calcium fluxes |
| 09/17/2009 | WO2009112537A1 Detecting analytes |
| 09/17/2009 | WO2009112498A1 Surface attachment |
| 09/17/2009 | WO2009112497A1 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation |
| 09/17/2009 | WO2009112448A1 Novel tool for the analysis of neural circuits |
| 09/17/2009 | WO2009112430A1 Method for detecting and quantifying a molecule including at least one proton group on a solid substrate |
| 09/17/2009 | WO2009112307A1 Use of procalcitonin (pct) in prognosis following acute coronary syndromes |
| 09/17/2009 | WO2009112199A1 Measuring method and measuring arrangement for determining the content of a chemical element or of another water quality parameter in freshwater or wastewater |
| 09/17/2009 | WO2009112158A1 Device and method for the contactless detection of characteristics of continuously delivered translucent products |
| 09/17/2009 | WO2009112075A1 Peptides and aptamers thereof as specific modulators of mutant p53 function |
| 09/17/2009 | WO2009112038A2 A microfluidic system and a method of performing a test |
| 09/17/2009 | WO2009112001A1 Method and device for the detection and identification of gases in airplane interior spaces |
| 09/17/2009 | WO2009111891A1 Diagnostic method for peanut allergy |
| 09/17/2009 | WO2009111881A1 Biomarkers for diagnosis of differentiated thyroid cancer |
| 09/17/2009 | WO2009111878A1 Quantification and affinity characterization of antibodies for the diagnosis of disease using optical diffraction |
| 09/17/2009 | WO2009111865A1 Reagents and methods for detecting influenza virus proteins |
| 09/17/2009 | WO2009094374A3 Method of selecting antioxidants for use in topically applied compositions |
| 09/17/2009 | WO2009094218A3 Novel cell lines expressing nav and methods using them |
| 09/17/2009 | WO2009092386A3 A new method to measure and characterize microvesicles in the human body fluids |
| 09/17/2009 | WO2009091926A3 Integrated magnetic field generation and detection platform |
| 09/17/2009 | WO2009090269A3 Markers and diagnostic methods for metastasis |
| 09/17/2009 | WO2009085575A3 Calibrator quality control cell device for immunohistochemistry assay and methods of use thereof |
| 09/17/2009 | WO2009085573A3 Quality control cell device for immunohistochemistry assay and methods of use thereof |
| 09/17/2009 | WO2009077731A3 Prolactin fusion proteins |
| 09/17/2009 | WO2009073155A3 Fluid sample collecting and analyzing apparatus |
| 09/17/2009 | WO2009063307A8 Inflammatory activity detection method using il-6 |
| 09/17/2009 | WO2009059972A3 Biochemical markers for cvd risk assessment |
| 09/17/2009 | WO2009047583A3 The use of acetic nitric acid reagent for extraction of oligosaccharides and polysaccharides to characterize carbohydrate materials from plants and other sources of cellulose using glycan oligomer analysis |
| 09/17/2009 | WO2009044243A3 Methods and apparatus for candling eggs via embryo heartbeat detection |
| 09/17/2009 | WO2009005651A3 Complement-mediated thrombophilic assay |
| 09/17/2009 | WO2008116178A8 Systems and methods for diagnosis and prognosis of colorectal cancer |
| 09/17/2009 | WO2007002579A3 Assay cartridges and methods for point of care instruments |
| 09/17/2009 | WO2006113840A8 Method of forming an auto-calibration label using a laser |
| 09/17/2009 | US20090235371 Diagnostic method |
| 09/17/2009 | US20090235369 Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses Thereof |
| 09/17/2009 | US20090235367 Non-human mammal comprising a modified SERCA2 gene and methods, cells, genes, and vectors thereof |
| 09/17/2009 | US20090234621 Method of optimizing parameters in the entire process of analysing a dna containing sample and method of modeling said process |
| 09/17/2009 | US20090234587 Measuring and analyzing multi-dimensional sensory information for identification purposes |
| 09/17/2009 | US20090234202 Method and compositions for highly sensitive detection of molecules |
| 09/17/2009 | US20090234101 Directed evolution of novel binding proteins |
| 09/17/2009 | US20090234020 Processes for the preparation of odesmethylvenlafaxine, free from its dimer impurities |
| 09/17/2009 | US20090233993 Compositions and methods for inhibiting gsk3 activity and uses thereof |
| 09/17/2009 | US20090233982 Methyltransferases and Their Uses |
| 09/17/2009 | US20090233971 GSK-3 Inhibitors |
| 09/17/2009 | US20090233963 Methods to determine suceptibility to treatment with leukotriene modifiers |
| 09/17/2009 | US20090233888 Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth |
| 09/17/2009 | US20090233872 Therapeutic Agent for Neurodegenerative Disease |
| 09/17/2009 | US20090233866 Screening Methods And The Use Of Agents Identified Using The Same |
| 09/17/2009 | US20090233859 modulating hepcidin and disease of iron metabolism such as hemochromatosis and anemia of chronic disease; adminstering soluble mammalian hemojuvelin protein |
| 09/17/2009 | US20090233858 Structure of a protein phosphatase 2a holoenzyme: insights into tau dephosphorylation |
| 09/17/2009 | US20090233855 Compounds and methods for modulating activation of nf-kb |
| 09/17/2009 | US20090233853 Use of outer membrane protein a in treatment/prevention/diagnosis of bacterial infection in central nervous system and/or peripheral blood circulation |
| 09/17/2009 | US20090233840 Modified Dynorphin Expression in Animals and Identification of Compounds for Treatment of Obesity and Diabetes |
| 09/17/2009 | US20090233811 Manufacture of Array Chips |
| 09/17/2009 | US20090233807 Assays that use the t1r1 receptor polypeptides to screen for t1r1-associated taste modulators |